Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells $23,232.44 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 7,543 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $3.08, for a total value of $23,232.44. Following the sale, the chief executive officer now owns 157,376 shares in the company, valued at approximately $484,718.08. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Amit Gupta also recently made the following trade(s):

• On Wednesday, July 24th, Amit Gupta sold 22,699 shares of Cardlytics stock. The shares were sold at an average price of $8.66, for a total value of $196,573.34.

Cardlytics Stock Up 7.5 %

Shares of NASDAQ:CDLX opened at $3.29 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.77 and a quick ratio of 1.77. The firm has a market capitalization of $160.50 million, a PE ratio of -0.74 and a beta of 1.67. The firm’s 50-day moving average is $4.24 and its two-hundred day moving average is $8.41. Cardlytics, Inc. has a 1 year low of $2.89 and a 1 year high of $20.52.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.12. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The business had revenue of $69.64 million during the quarter, compared to the consensus estimate of $75.39 million. During the same period in the previous year, the company posted ($0.57) earnings per share. The business’s revenue for the quarter was down 9.2% on a year-over-year basis. Analysts predict that Cardlytics, Inc. will post -1.72 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Lake Street Capital downgraded Cardlytics from a “buy” rating to a “hold” rating and reduced their target price for the stock from $18.00 to $5.00 in a research note on Thursday, August 8th. Needham & Company LLC downgraded Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Craig Hallum lowered Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. Bank of America lowered Cardlytics from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $4.00 to $3.50 in a report on Thursday, August 15th. Finally, Northland Capmk lowered shares of Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. One investment analyst has rated the stock with a sell rating and five have given a hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $7.50.

Hedge Funds Weigh In On Cardlytics

Several hedge funds have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC boosted its position in shares of Cardlytics by 711.9% in the 2nd quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock valued at $2,882,000 after purchasing an additional 307,800 shares during the period. Kent Lake Capital LLC purchased a new stake in shares of Cardlytics in the first quarter valued at about $3,622,000. Perbak Capital Partners LLP purchased a new stake in shares of Cardlytics in the first quarter valued at about $2,348,000. General Equity Holdings LP boosted its holdings in shares of Cardlytics by 31.0% in the fourth quarter. General Equity Holdings LP now owns 624,058 shares of the company’s stock valued at $5,748,000 after acquiring an additional 147,843 shares in the last quarter. Finally, Blackstone Inc. purchased a new stake in shares of Cardlytics in the first quarter valued at about $2,029,000. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.